U.S. Software Stock News

As an investor its worth striving to ensure your overall portfolio beats the market average. But in any portfolio...

Rockwell Medical, Inc. ( NASDAQ:RMTI ) shares have had a horrible month, losing 32% after a relatively good period...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

If you’re watching United Bankshares and trying to figure out your next move, you’re not alone. The stock recently closed at $35.53, and while it’s dipped about 4.5% over the past week and a bit more in the last month, the longer-term story is a bit more stable. Over the last year, United Bankshares is down only 0.5%, and if you zoom out even further, the stock is actually up an impressive 79.6% over five years. These numbers point to both short-term headwinds and underlying long-term...

Worthington Steel (WS) reported net profit margins of 3.8%, edging out last year’s 3.7%, even as the company continues to face pressure from declining earnings. The five-year average shows earnings have dropped 9% annually and dipped again this year. Looking ahead, analysts expect earnings to bounce back at a 7.7% rate annually, with revenue forecasted for 3.5% growth per year. Shares are trading at a price-to-earnings ratio of 12.5x, undercutting both the peer average of 27.9x and the...

Even the best stock pickers will make plenty of bad investments. Unfortunately, shareholders of Wabash National...

Franklin Covey Co. ( NYSE:FC ), is not the largest company out there, but it saw significant share price movement...

Whilst it may not be a huge deal, we thought it was good to see that the The Children's Place, Inc. ( NASDAQ:PLCE...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...

Central Bancompany (CBCY) reported earnings growth of 10.8% over the past year, outpacing its 5-year average of 6.8% per year. Net profit margins expanded to 36.3%, up from 35.1% a year ago, and earnings quality remains high. With no material risks flagged and ongoing profit or revenue growth, the current results add fuel for a more positive investor sentiment around the shares. See our full analysis for Central Bancompany. Next up, we dig into how these latest figures stack up against the...

Thinking about whether Exponent is a buy, sell, or hold right now? You’re not alone, especially with so much chatter in the market about where expert consulting firms like this one fit into the bigger investing picture. Let’s take a quick look at the numbers: over the past year, Exponent’s stock has dropped over 41%, and it has slid steadily this year as well. In the past week alone, shares moved down 2.7%, and for the past month, the decline was 6.8%. Even zooming out to three and five...

Hingham Institution for Savings (HIFS) posted net profit margins of 49.9% for the year, a marked jump from 39.6% twelve months ago, with EPS-powered earnings growing 95.4%. Despite this impressive surge, the company’s five-year record shows earnings declined by an average of 17.9% per year. Shares are trading at $272.18, representing a Price-to-Earnings ratio of 13.1x, notably above both the US Banks industry average (11.3x) and its peers (12.1x), and well over the fair value estimate of...

Trying to decide what to do with TELUS International (Cda) stock? You are not alone. This is one of those names that has people wondering if the tides are finally turning, or if caution is still the right call. After a challenging few years, TELUS International's share price has caught some positive momentum, climbing 12.0% year-to-date and up 17.3% over the past year. But let’s be real. The memory of that steep 82.3% drop over the last three years is hard to ignore for any investor who’s...

One and one Green Technologies (NasdaqCM:YDDL) recently completed its widely discussed initial public offering on the Nasdaq. The event drew attention as shares jumped sharply in both premarket and after-hours trading on debut. See our latest analysis for One and one Green Technologies. The early days of trading for One and one Green Technologies have been anything but quiet. Following its Nasdaq debut, the company’s share price surged for a 1-day share price return of 21.03%, propelled by a...

aTyr Pharma recently reported that its Phase 3 trial for efzofitimod in pulmonary sarcoidosis failed to meet its primary endpoint, leading to a wave of investor class action lawsuits alleging misleading statements about the drug’s efficacy. There is significant investor scrutiny on the company’s prior disclosures and communications, as legal investigations focus on the statements made during the trial period. We’ll examine how the trial failure and rising legal challenges may impact aTyr...

LENZ Therapeutics announced the nationwide availability of VIZZ, its FDA-approved aceclidine-based eye drop for presbyopia, with product sample distribution to eye care professionals and commercial shipments to consumers expected to begin soon. VIZZ is the first and only aceclidine-based eye drop approved by the FDA for presbyopia, featuring a unique, primarily pupil-selective mechanism of action that significantly improves near vision without causing a myopic shift. We’ll now examine how...

If you have been staring at Churchill Downs stock, weighing whether to wait out the losses or jump in for a potential rebound, you are not alone. The company has faced significant pressure this year, with shares down 31.6% year-to-date and off 35.1% over the last twelve months. That is not a typo, and it is natural to feel cautious when the recent 7-day and 30-day returns have also been negative, falling by 6.2% and 6.5% respectively. Long-term holders see only a modest 5.2% gain over five...

Accenture (ACN) reported earnings growth of 5.7% year-over-year, trailing its own 5-year average annual earnings growth of 7.4%. The company’s net profit margin dipped slightly to 11% from 11.2% a year earlier, and while revenue is forecast to rise by 5.3% per year going forward, this is below the broader US market’s 9.9% projected growth rate. For investors, the results point to a balance of predictability and quality in earnings, with the current share price of $240.94 remaining below...

loanDepot (LDI) shares have seen a mild push upwards lately, trading near $3.07 after gaining almost 2% in the past week. Investors may be eyeing recent momentum, even though the stock has experienced a tough month. See our latest analysis for loanDepot. loanDepot has seen a burst of optimism lately, but that comes after a rocky stretch, including a 1-month share price return of -28.1%. Still, the momentum in 2024 is striking, with the share price up more than 57% year-to-date and an...

Figuring out what to do with Dynex Capital stock? You are definitely not alone, and the numbers are giving investors plenty to talk about. Dynex Capital has quietly posted an impressive 23.5% gain over the last year, building on a multi-year performance that includes a near 70% jump since three years ago. After a period of steady growth, the stock has recently closed at $12.98. These gains reflect more than just company fundamentals, as investor perception towards interest rates and real...

U.S. GoldMining reported third-quarter results that changed from a net loss to a net profit. The company also showed smaller losses over the first nine months of 2025 compared to last year. These earnings have caught the eye of investors. See our latest analysis for U.S. GoldMining. Thanks to its swing from losses to profit, U.S. GoldMining has sparked a surge in investor optimism, with the share price jumping 46.5% over the past month and 80.3% in the last 90 days. The year-to-date share...

Trying to decide what to do with your DRDGOLD stock or thinking about jumping in? You are not alone. Over the past year, DRDGOLD’s price has been anything but boring, rising a stunning 179.9% over the last 12 months and delivering a massive 218.8% year-to-date. In just the last month, the stock has added another 25.6%, leaving most of the sector in the dust. Even in the last week, it edged up a solid 0.5%, showing resilience as investors weigh shifting signals in the gold market. Part of this...

Trying to figure out whether to buy, sell, or hold ALLETE? You are not alone. Plenty of investors are taking a close look at the company's recent run. ALLETE’s stock price has posted some quietly impressive gains, up 5.5% over the last month and 9.4% in the past year. That solid uptrend hints at renewed investor optimism, possibly connected to ongoing shifts in the energy sector and investor confidence in utilities. Over longer timeframes, ALLETE’s performance stands out even more, with...